Product Overview
Clone: KRT19/799
Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/799 is a monoclonal antibody specifically designed to recognize Cytokeratin 19, a type I intermediate filament protein expressed in simple epithelial cells and a wide range of epithelial-derived tumors. Recognized as a marker for pancreatic stem and progenitor cells, KRT19 is valuable in both research and diagnostic applications for identifying tumors with stem-like or undifferentiated features. Clone KRT19/799 exhibits strong and specific immunoreactivity in formalin-fixed, paraffin-embedded (FFPE) tissues, making it highly effective for immunohistochemical analysis. It is commonly used in the detection and classification of carcinomas from tissues such as the pancreas, liver, thyroid, breast, and gastrointestinal tract, as well as for detecting micrometastases in lymph nodes. The concentrated format allows for flexible protocol optimization. With its high specificity and consistent performance, Clone KRT19/799 serves as a reliable tool for tumor profiling, aiding in accurate diagnosis and cancer research.
